The share price of IBN SINA has maintained
the following price sequence which attracted me to buy this share. I
hope this sequence will repeat again. Expected profit gap Tk.48 (17.49%)
Tuesday, August 22, 2017
Sunday, August 20, 2017
ORION INFUSION has created a rising wedge pattern confirming it's future down trend.
It's now risky to buy this share. Price may fall to Tk.52.20
Disclaimer: This is simply a forecast. I don't take any responsibilities for consequential loss if any.
JMI SYRINGE share price may reverse it's direction after touching Tk.220.20.
It's now safe to take profit from JMI SYRINGE. The share price may reverse after touching Tk.220.20.
Friday, August 11, 2017
LAFARGE SURMA successfully breakout the 61.80 resistance line
I am happy to see that the 58 support line was perfectly
worked. The price was successfully broken out the 61.80 resistance line and
going ahead to Tk.64 which is strong. If it's able to break out the 64 line,
then it may go Tk.66. My recommendation it will better sell shares at Tk.64.
LAFARGE at Different
time Interval:
|
Time Interval
|
Trend
|
|
Daily
|
Bullish
|
|
Weekly
|
Bullish
|
|
Monthly
|
Bearish (Considering Price-volume Matrix)
|
This analysis prepared keeping in mind to have a short term investment.
This
analysis is purely technical, no fundamental facts or factor is used here.
Disclaimer: This is simply a forecast. I don't take any
responsibilities for consequential loss if any.
Wednesday, August 9, 2017
BD FINANCE
If its successfully breakout the 19.80 line & close above Tk.19.90 then it may go Tk.21.50.
Disclaimer: This is simply a forecast. I don't take any responsibilities for consequential loss if any.
Disclaimer: This is simply a forecast. I don't take any responsibilities for consequential loss if any.
GEMINISEA
The share price of GEMINISEA may increase from existing price level. Target price is Tk.645.
Disclaimer: This is simply a forecast. I don't take any responsibilities for consequential loss if any.
Disclaimer: This is simply a forecast. I don't take any responsibilities for consequential loss if any.
Tuesday, August 8, 2017
BEACON PHARMA
It's now risky to buy this share. Price may reverse from any of this two price levels. (21.50 or 20.80)
Disclaimer: This is simply a forecast. I don't take any responsibilities for consequential loss if any.
Disclaimer: This is simply a forecast. I don't take any responsibilities for consequential loss if any.
Subscribe to:
Posts (Atom)